Background-Charcot-Marie-Tooth dis-
Short tandem repeat genotype analysis was performed with the chromosome lp35-p36 markers D1S160 (MIT-MS48), D1S170 (MIT-COS37), D1S244 (AFM220yf4), and D1S228 (AFM196xb4); the chromosome 3ql3-q22 markers D3S1769 (GATA8DO2), D3S1267 (AFM116xh2), D3S1551 (AFM198ycl), D3S1290 (AFM198yh6), D3S1764 (GATA4A10), and D3S1744 (GATA3CO2); the chromosome 7pl4 markers D7S435 (Mfd2O) and D7S 1806 (GGAA1 1Ci1); and the chromosome 9q22 markers, D9S196 (AFM212yb4), D9S197 (AFM238va7), and D9S280 (AFM304td9). 6'2 Genomic DNA (0,15,ug) was amplified using oligonucleotide primers labelled with fluorophores (Applied Biosystems Incorporation, ABI, Foster City, CA, USA). A polymerase chain reaction (PCR) was performed in a 25 Ml reaction volume containing 10 pmol of each primer and 0-1 U Goldstar Taq DNA polymerase (Eurogentec, Belgium). The PCR amplifications were performed in a thermal cycler (Techne PHC-3; New Brunswick Scientific, The Netherlands). An aliquot of 1 MI of each amplified product was mixed with 2,l formamide and 0 5 MI fluorescent labelled size standard GS350-ROX (ABI) and denatured for three minutes at 950C. The samples were loaded on 4% polyacrylamide sequencing gels and electrophoresed in an ABI automated DNA sequencer 377. Finally, the data were collected and analysed using ABI GENESCAN software. The haplotypes were constructed according to the genetic map of The patients in the CMT2B family reported Our results confirm the presence of a HMSN II gene on chromosome 3q13-q22 and refine the CMT2B candidate region. There is a striking clinical similarity between our CMT-90 family and the one reported by Kwon et al.7 The clinical similarity between these two families suggests that the prominent sensory features form an integral part of the CMT 2B phenotype. 
